Bioactivity:

CTP499, a selective PDE inhibitor, and the deuterium-containing agent is an HDX analogue and a metabolite of hexantheobromine that slows the progression of type 2 diabetic nephropathy in patients with macroalbuminuria.

CAS nr:

1268605-91-9

Purity:

98%

Molecular Weight:

285,36

SMILES:

O=C(N1CCCC([2H])([2H])[C@@H](O)C([2H])([2H])[2H])N(C)C2=C(N(C)C=N2)C1=O

Formula:

C13H15D5N4O3

Pathway:

Target: